Drug Search Results
More Filters [+]

AIRCURVETM-10

Alternative Names: aircurvetm-10, aircurvetm10, aircurvetm 10
Latest Update: 2022-06-29
Latest Update Note: Clinical Trial Update

Product Description

For adaptive servo-ventilation, indicated and approved for clinical use in Switzerland, European Union, and other countries (Sourced from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820538/)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Insel Gruppe AG, University Hospital Bern
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for AIRCURVETM-10

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

eSATIS

N/A

Unknown status

Sleep Apnea, Central|Stroke|Sleep Apnea, Obstructive

2022-03-05

Recent News Events

Date

Type

Title